SlideShare uma empresa Scribd logo
1 de 32
PREPARED BY,
DEVIPRIYA P V
M PHARM
DEPARTMENT OF PHARMACEUTICAL ANALYSIS
“Confirmation by examination and provision of objective
evidence that computer system specifications conform to user
needs and intended uses and that all requirements can be
consistently fulfilled”.
2
 Ensure an acceptable degree of documented evidence that
establishes confidence in the accuracy, reliability and
consistency in performance of the system.
 Meet the principles ALCOA.
 Ensure that all technical and procedural controls are
implemented ensuring compliance with good documentation
practices for electronic data generated by the system
3
4
VALIDATION
The computerized system shall be validated in accordance with
the Corporate Standards and regulatory requirements to ensure:
 Accuracy.
 Reliability.
 Consistent Intended Performance.
 Ability to discern invalid or altered records.
 Evidence of validation.
5
CSVMP
 Describes the policy, approach, organization and planning,
resources, execution and management of computerized
system validation for all of the GXP systems in use on-site.
 Contain, the scope, risk management approach and a
complete inventory list of all GXP systems.
 Validation should be executed in accordance with the
validation protocol and applicable SOPs.
6
7
 Validation report outlines the validation process and activities
and describe and justify any deviations from the process and
activities specified in the protocol.
 Design qualification .
 Installation qualification.
 Operational qualification.
:hardware qualification
:software qualification.
 Standard operating procedures and training.
 Performance qualification.
HARDWARE QUALIFICATION
 The qualification of the hardware should prove:
 capacity of the hardware matches its assigned function.
 operates within the operational limits
 hardware configuration settings are appropriate and meet
user and functional requirements;
 performs acceptably under challenging conditions
 reproducibility/consistency.
8
SOFTWARE QUALIFICATION
 Functional testing of software should provide assurance that
computer programs will function consistently within pre-
established limits for both normal conditions as well as under
worst-case conditions.
 Functional testing, also known as “black box” testing,
involves inputting normal and abnormal test cases; then,
evaluating outputs against those expected.
9
SYSTEM OPERATION AND MAINTENANCE
 Periodically reviewed to determine whether the system
remains in a validated state or whether there is a need for
revalidation.
 The review should cover:
• review of changes;
• review of deviations;
• review of incidents;
• systems documentation;
• procedures;
• training;
• effectiveness of corrective and preventive action (CAPA). 10
21 CFR PART 11
 CFR stands for Code of Federal Regulations and refers to a
document listing United States Federal Regulations.
 The number "21" is short for "Title 21, Chapter I," and the
number "11," for "Part 11“.
 Title 21 concerns the area of Food and Drugs, Chapter I is the
section related to FDA, and Part 11 is the sub-section of this
chapter, which focuses on a specific area (i.e., Electronic
Records; Electronic Signatures)
11
IMPORTANCE OF 21 CFR PART11
 Guidelines on how to manage electronic records and
electronic signatures in order to maintain accuracy and
security.
 Help FDA-regulated companies obtain the benefits of
electronic data management.
 Prevent fraud while permitting the widest possible use of
electronic technology.
 Guidelines that establish which electronic records and
signatures can be considered equivalent to paper records and
handwritten signatures.
12
 Part 11 requires:
(1) Controlled access;
(2) Computer generated audit trails;
(3) Electronic digital signatures.
13
14
ELECTRONIC RECORDS:
Any combination of text, graphics, data, audio, pictorial, or
other information representation in digital form that is
created, modified, maintained, archived, retrieved, or
distributed by a computer system.
ELECRONIC SIGNATURE:
A computer data compilation of any symbol or series of
symbols executed, adopted, or authorized by an individual to
be the legally binding equivalent of the individual's
handwritten signature.
15
ELECTRONIC RECORDS
 Secure process values and audit trails .
 Protection of data through binary, compressed and check-
summed records .
 Accurate time stamps are ensured using automatic Time
Synchronization to a known clock source .
 Provision for electronically copying data for archive .
 Export facility providing viewing of secure records in human
readable form.
16
ELECTRONIC SIGNATURE
 All user actions can be configured to require signing or require
signing and authorization .
 User specific access according to authority level .
 controls unique user signature, password expiry, minimum
password length, automatic log-off, automatic disabling and
notification of failed login attempts .
 Ensuring unique users by retiring and not deleting accounts
17
ADVANTAGES
 Electronic Batch records can eliminate mountains of paper
work, speed processing and allow for statistical and trend
analyses.
 NDA’s and other submissions can be submitted electronically
in place of paper submission.
 Increases the speed of information exchange.
 Cost savings from reduced need for storage space.
 Manufacturing process streamlining.
 Job creation in industries involved in electronic record and
electronic signature technologies.
18
APPLICATIONS
 Section 11.10 describes controls for closed systems.
 These controls designed to ensure the integrity of system
operations and information stored in the system.
 Section 11.30 describes controls for open system .
 Develop procedures and controls that ensure authenticity,
integrity, and confidentiality of electronic records and comply
with all other parts of Section 11.10
 Must use additional measures to ensure authenticity,
integrity, and confidentiality. 19
20
Section 11.70:
Signature / record linking
Electronic signature and handwritten signatures must be
linked to ensure signatures cannot be excised, copied,
transferred or falsified.
Section 11.50:
It requires signature manifestations to contain information
associated with the signing of electronic record.
 Signed electronic records must include :
 printed name of the signer
 date and time of signature
 the purpose of the signature (e.g. review, approval etc.)
 Each of these must be readable by display or printout.
21
Section 11.100:
 Must be unique to an individual and not reassigned
 Identity of individual must be verified by organization
 Must certify electronic signature system to the agency prior to
or at the time of use of the system
 Certification must be submitted in paper form and, upon
agency request, provide certification that signature is legally
binding
22
Section 11.200:
 Electronic Signature Components and Controls.
 Non biometric signatures must:
 Contain at least two different identification components
 Be used only by the owner
 Ensure use by other individuals is precluded and does not
occur without collaboration by at least two other
individuals
 Biometric signatures must ensure use by the owner.
23
Section 11.300:
 Controls for Identification Codes/Passwords.
 Persons using electronic signatures must use controls to
ensure security and integrity should include:
 Assuring that no two individuals have the same
combination of identification code and password
 Periodic check, recall of code and password
 Loss management and replacement procedures.
 Unauthorized use safeguards
 Report attempts in urgent & immediate manner
 Security unit
 Management, as appropriate
GAMP 5
 GAMP5 guidance aims to achieve computerized systems that
are fit for intended use and meet current regulatory
requirements, by building upon existing industry good
practice in an efficient and effective manner.
24
The purpose of the guidelines is to:
 Provide a cost effective framework of good practice to ensure
that computerized systems are fit for use and compliant with
regulation.
Key concepts to GAMP 5:
 Product and Process Understanding.
 Lifecycle approach within QMS.
 Scalable Lifecycle Activities.
 Science Based Quality Risk Management.
 Leveraging Supplier Involvement.
25
STRUCTURE OF GAMP5
26
27
 GAMP 5 sets the main requirements for the use of
computerized systems in pharmaceutical applications:
 Patient safety, product quality and data integrity.
 Effective governance to achieve and maintain GxP
compliance.
 Quality by design (QBD).
 Continuous improvement with in QMS.
 Critical quality attributes (CQA).
28
 Improving GXP compliance efficiency.
 Configurable systems and development models.
 Use of existing documentation and knowledge.
 Effective supplier relationships.
 Scalable approach to GXP compliance.
 Science based quality risk management system.
 Life cycle approach within QMS.
29
GAMP5 illustrates the specification, design, and
verification process
30
APPLICATIONS
1. Monitoring manufacturing, production and storage
environments in the pharmaceutical industry.
2. Monitoring the autoclaving process in the pharmaceutical
industry.
3. Water purification in the pharmaceutical industry.
4. Freeze drying in the pharmaceutical industry.
31
32

Mais conteúdo relacionado

Mais procurados

Pharmaceutical validation, Quantification, streamlining, validation masterplan.
Pharmaceutical validation, Quantification, streamlining, validation masterplan.Pharmaceutical validation, Quantification, streamlining, validation masterplan.
Pharmaceutical validation, Quantification, streamlining, validation masterplan.
begalavenu
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
RavichandraNadagouda
 

Mais procurados (20)

Qualification Of HPTLC
Qualification Of HPTLCQualification Of HPTLC
Qualification Of HPTLC
 
Qualification of HPLC
Qualification of HPLCQualification of HPLC
Qualification of HPLC
 
Qualification of manufacturing equipment.
Qualification of manufacturing equipment.Qualification of manufacturing equipment.
Qualification of manufacturing equipment.
 
Pharmaceutical validation, Quantification, streamlining, validation masterplan.
Pharmaceutical validation, Quantification, streamlining, validation masterplan.Pharmaceutical validation, Quantification, streamlining, validation masterplan.
Pharmaceutical validation, Quantification, streamlining, validation masterplan.
 
QUALIFICATION OF HPLC , HPLC
QUALIFICATION OF HPLC , HPLCQUALIFICATION OF HPLC , HPLC
QUALIFICATION OF HPLC , HPLC
 
Validation of pharaceutical water system and pure steam
Validation of pharaceutical water system and pure steamValidation of pharaceutical water system and pure steam
Validation of pharaceutical water system and pure steam
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
CLEANING METHOD DEVELOPMENT
CLEANING METHOD DEVELOPMENT CLEANING METHOD DEVELOPMENT
CLEANING METHOD DEVELOPMENT
 
QUALIFICATION OF HPTLC,HPTLC
QUALIFICATION  OF HPTLC,HPTLCQUALIFICATION  OF HPTLC,HPTLC
QUALIFICATION OF HPTLC,HPTLC
 
Qualification of high performance liquid chromatography
Qualification of high performance liquid chromatographyQualification of high performance liquid chromatography
Qualification of high performance liquid chromatography
 
cGMP Guidelines According to Schedule M
cGMP Guidelines According to Schedule McGMP Guidelines According to Schedule M
cGMP Guidelines According to Schedule M
 
Requalification
RequalificationRequalification
Requalification
 
Qualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri SoniQualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri Soni
 
Qualification Of HPLC
Qualification Of HPLCQualification Of HPLC
Qualification Of HPLC
 
Qualification of analytical instruments
Qualification of analytical instrumentsQualification of analytical instruments
Qualification of analytical instruments
 
Pharmaceutical validation of water system
Pharmaceutical validation of  water system Pharmaceutical validation of  water system
Pharmaceutical validation of water system
 
Validation utility system
Validation utility systemValidation utility system
Validation utility system
 
Qualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility SystemQualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility System
 
USFDA guidelines on process validation a life cycle approach
USFDA guidelines on process validation a life cycle approachUSFDA guidelines on process validation a life cycle approach
USFDA guidelines on process validation a life cycle approach
 
Qualification of laboratory equipments
Qualification of laboratory equipmentsQualification of laboratory equipments
Qualification of laboratory equipments
 

Semelhante a Computerized system validation

WP_UL Compliance wth 21CFR Part_11
WP_UL Compliance wth 21CFR Part_11WP_UL Compliance wth 21CFR Part_11
WP_UL Compliance wth 21CFR Part_11
Jamie Corn, MBA
 
Auditing by CIS . Chapter 6
Auditing by CIS . Chapter 6Auditing by CIS . Chapter 6
Auditing by CIS . Chapter 6
Sharah Ayumi
 

Semelhante a Computerized system validation (20)

Computerized system validation
Computerized system validationComputerized system validation
Computerized system validation
 
WP_UL Compliance wth 21CFR Part_11
WP_UL Compliance wth 21CFR Part_11WP_UL Compliance wth 21CFR Part_11
WP_UL Compliance wth 21CFR Part_11
 
Calibration/PM and Asset Management in Bio-Med Applications
Calibration/PM and Asset Management in Bio-Med ApplicationsCalibration/PM and Asset Management in Bio-Med Applications
Calibration/PM and Asset Management in Bio-Med Applications
 
eQMS validation
eQMS validationeQMS validation
eQMS validation
 
Computerized System Validation : Understanding basics
Computerized System Validation : Understanding basics Computerized System Validation : Understanding basics
Computerized System Validation : Understanding basics
 
Phụ lục 11 GMPEU. Hệ thống máy tính
Phụ lục 11 GMPEU. Hệ thống máy tínhPhụ lục 11 GMPEU. Hệ thống máy tính
Phụ lục 11 GMPEU. Hệ thống máy tính
 
Beamex CMX and GAMP good automated manufacturing practices
Beamex CMX and GAMP good automated manufacturing practicesBeamex CMX and GAMP good automated manufacturing practices
Beamex CMX and GAMP good automated manufacturing practices
 
Overview of computer system validation
Overview of computer system validationOverview of computer system validation
Overview of computer system validation
 
Auditing by CIS . Chapter 6
Auditing by CIS . Chapter 6Auditing by CIS . Chapter 6
Auditing by CIS . Chapter 6
 
The 21 CFR Part 11 Compliance Checklist for Digital Applications
The 21 CFR Part 11 Compliance Checklist for Digital ApplicationsThe 21 CFR Part 11 Compliance Checklist for Digital Applications
The 21 CFR Part 11 Compliance Checklist for Digital Applications
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11
 
IT and part 11
IT and part 11IT and part 11
IT and part 11
 
Auditing In Computer Environment Presentation
Auditing In Computer Environment PresentationAuditing In Computer Environment Presentation
Auditing In Computer Environment Presentation
 
Chapter 6
Chapter 6Chapter 6
Chapter 6
 
Overview on “Computer System Validation” CSV
Overview on  “Computer System Validation” CSVOverview on  “Computer System Validation” CSV
Overview on “Computer System Validation” CSV
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validation
 
Network Security & Assured Networks: TechNet Augusta 2015
Network Security & Assured Networks: TechNet Augusta 2015Network Security & Assured Networks: TechNet Augusta 2015
Network Security & Assured Networks: TechNet Augusta 2015
 
21 cfr part 11 compliance
21 cfr part 11 compliance21 cfr part 11 compliance
21 cfr part 11 compliance
 
Computer system overview
Computer system overviewComputer system overview
Computer system overview
 
ch10.pptx
ch10.pptxch10.pptx
ch10.pptx
 

Mais de Devipriya Viswambharan

Mais de Devipriya Viswambharan (20)

Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
 
Nucleic acid metabolism and genetic information transfer
Nucleic acid metabolism and genetic information transferNucleic acid metabolism and genetic information transfer
Nucleic acid metabolism and genetic information transfer
 
Sexually transmitted diseases
Sexually transmitted diseasesSexually transmitted diseases
Sexually transmitted diseases
 
Lipid metabolism
Lipid metabolismLipid metabolism
Lipid metabolism
 
Amino acid metabolism
Amino acid metabolismAmino acid metabolism
Amino acid metabolism
 
Surface infection
Surface infectionSurface infection
Surface infection
 
Arthropod borne infections
Arthropod borne infectionsArthropod borne infections
Arthropod borne infections
 
Biological oxidation
Biological oxidationBiological oxidation
Biological oxidation
 
Carbohydrate metabolism
Carbohydrate metabolismCarbohydrate metabolism
Carbohydrate metabolism
 
Solid waste disposal and control
Solid waste disposal and controlSolid waste disposal and control
Solid waste disposal and control
 
Respiratory infections
Respiratory infectionsRespiratory infections
Respiratory infections
 
Medical entamology
Medical entamologyMedical entamology
Medical entamology
 
Intestinal infection
Intestinal infectionIntestinal infection
Intestinal infection
 
Fundamental principles of microbiology
Fundamental principles of microbiologyFundamental principles of microbiology
Fundamental principles of microbiology
 
Enzymes
EnzymesEnzymes
Enzymes
 
Environment and health water
Environment and health   waterEnvironment and health   water
Environment and health water
 
Biomolecules carbohydrates, lipids, nucleic acid
Biomolecules  carbohydrates, lipids, nucleic acidBiomolecules  carbohydrates, lipids, nucleic acid
Biomolecules carbohydrates, lipids, nucleic acid
 
Biomolecules amino acids and proteins
Biomolecules   amino acids and proteinsBiomolecules   amino acids and proteins
Biomolecules amino acids and proteins
 
Bioenergetics
BioenergeticsBioenergetics
Bioenergetics
 
Air, noise, lighting
Air, noise, lightingAir, noise, lighting
Air, noise, lighting
 

Último

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 

Último (20)

Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 

Computerized system validation

  • 1. PREPARED BY, DEVIPRIYA P V M PHARM DEPARTMENT OF PHARMACEUTICAL ANALYSIS
  • 2. “Confirmation by examination and provision of objective evidence that computer system specifications conform to user needs and intended uses and that all requirements can be consistently fulfilled”. 2
  • 3.  Ensure an acceptable degree of documented evidence that establishes confidence in the accuracy, reliability and consistency in performance of the system.  Meet the principles ALCOA.  Ensure that all technical and procedural controls are implemented ensuring compliance with good documentation practices for electronic data generated by the system 3
  • 4. 4
  • 5. VALIDATION The computerized system shall be validated in accordance with the Corporate Standards and regulatory requirements to ensure:  Accuracy.  Reliability.  Consistent Intended Performance.  Ability to discern invalid or altered records.  Evidence of validation. 5
  • 6. CSVMP  Describes the policy, approach, organization and planning, resources, execution and management of computerized system validation for all of the GXP systems in use on-site.  Contain, the scope, risk management approach and a complete inventory list of all GXP systems.  Validation should be executed in accordance with the validation protocol and applicable SOPs. 6
  • 7. 7  Validation report outlines the validation process and activities and describe and justify any deviations from the process and activities specified in the protocol.  Design qualification .  Installation qualification.  Operational qualification. :hardware qualification :software qualification.  Standard operating procedures and training.  Performance qualification.
  • 8. HARDWARE QUALIFICATION  The qualification of the hardware should prove:  capacity of the hardware matches its assigned function.  operates within the operational limits  hardware configuration settings are appropriate and meet user and functional requirements;  performs acceptably under challenging conditions  reproducibility/consistency. 8
  • 9. SOFTWARE QUALIFICATION  Functional testing of software should provide assurance that computer programs will function consistently within pre- established limits for both normal conditions as well as under worst-case conditions.  Functional testing, also known as “black box” testing, involves inputting normal and abnormal test cases; then, evaluating outputs against those expected. 9
  • 10. SYSTEM OPERATION AND MAINTENANCE  Periodically reviewed to determine whether the system remains in a validated state or whether there is a need for revalidation.  The review should cover: • review of changes; • review of deviations; • review of incidents; • systems documentation; • procedures; • training; • effectiveness of corrective and preventive action (CAPA). 10
  • 11. 21 CFR PART 11  CFR stands for Code of Federal Regulations and refers to a document listing United States Federal Regulations.  The number "21" is short for "Title 21, Chapter I," and the number "11," for "Part 11“.  Title 21 concerns the area of Food and Drugs, Chapter I is the section related to FDA, and Part 11 is the sub-section of this chapter, which focuses on a specific area (i.e., Electronic Records; Electronic Signatures) 11
  • 12. IMPORTANCE OF 21 CFR PART11  Guidelines on how to manage electronic records and electronic signatures in order to maintain accuracy and security.  Help FDA-regulated companies obtain the benefits of electronic data management.  Prevent fraud while permitting the widest possible use of electronic technology.  Guidelines that establish which electronic records and signatures can be considered equivalent to paper records and handwritten signatures. 12
  • 13.  Part 11 requires: (1) Controlled access; (2) Computer generated audit trails; (3) Electronic digital signatures. 13
  • 14. 14
  • 15. ELECTRONIC RECORDS: Any combination of text, graphics, data, audio, pictorial, or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system. ELECRONIC SIGNATURE: A computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be the legally binding equivalent of the individual's handwritten signature. 15
  • 16. ELECTRONIC RECORDS  Secure process values and audit trails .  Protection of data through binary, compressed and check- summed records .  Accurate time stamps are ensured using automatic Time Synchronization to a known clock source .  Provision for electronically copying data for archive .  Export facility providing viewing of secure records in human readable form. 16
  • 17. ELECTRONIC SIGNATURE  All user actions can be configured to require signing or require signing and authorization .  User specific access according to authority level .  controls unique user signature, password expiry, minimum password length, automatic log-off, automatic disabling and notification of failed login attempts .  Ensuring unique users by retiring and not deleting accounts 17
  • 18. ADVANTAGES  Electronic Batch records can eliminate mountains of paper work, speed processing and allow for statistical and trend analyses.  NDA’s and other submissions can be submitted electronically in place of paper submission.  Increases the speed of information exchange.  Cost savings from reduced need for storage space.  Manufacturing process streamlining.  Job creation in industries involved in electronic record and electronic signature technologies. 18
  • 19. APPLICATIONS  Section 11.10 describes controls for closed systems.  These controls designed to ensure the integrity of system operations and information stored in the system.  Section 11.30 describes controls for open system .  Develop procedures and controls that ensure authenticity, integrity, and confidentiality of electronic records and comply with all other parts of Section 11.10  Must use additional measures to ensure authenticity, integrity, and confidentiality. 19
  • 20. 20 Section 11.70: Signature / record linking Electronic signature and handwritten signatures must be linked to ensure signatures cannot be excised, copied, transferred or falsified. Section 11.50: It requires signature manifestations to contain information associated with the signing of electronic record.  Signed electronic records must include :  printed name of the signer  date and time of signature  the purpose of the signature (e.g. review, approval etc.)  Each of these must be readable by display or printout.
  • 21. 21 Section 11.100:  Must be unique to an individual and not reassigned  Identity of individual must be verified by organization  Must certify electronic signature system to the agency prior to or at the time of use of the system  Certification must be submitted in paper form and, upon agency request, provide certification that signature is legally binding
  • 22. 22 Section 11.200:  Electronic Signature Components and Controls.  Non biometric signatures must:  Contain at least two different identification components  Be used only by the owner  Ensure use by other individuals is precluded and does not occur without collaboration by at least two other individuals  Biometric signatures must ensure use by the owner.
  • 23. 23 Section 11.300:  Controls for Identification Codes/Passwords.  Persons using electronic signatures must use controls to ensure security and integrity should include:  Assuring that no two individuals have the same combination of identification code and password  Periodic check, recall of code and password  Loss management and replacement procedures.  Unauthorized use safeguards  Report attempts in urgent & immediate manner  Security unit  Management, as appropriate
  • 24. GAMP 5  GAMP5 guidance aims to achieve computerized systems that are fit for intended use and meet current regulatory requirements, by building upon existing industry good practice in an efficient and effective manner. 24
  • 25. The purpose of the guidelines is to:  Provide a cost effective framework of good practice to ensure that computerized systems are fit for use and compliant with regulation. Key concepts to GAMP 5:  Product and Process Understanding.  Lifecycle approach within QMS.  Scalable Lifecycle Activities.  Science Based Quality Risk Management.  Leveraging Supplier Involvement. 25
  • 27. 27
  • 28.  GAMP 5 sets the main requirements for the use of computerized systems in pharmaceutical applications:  Patient safety, product quality and data integrity.  Effective governance to achieve and maintain GxP compliance.  Quality by design (QBD).  Continuous improvement with in QMS.  Critical quality attributes (CQA). 28
  • 29.  Improving GXP compliance efficiency.  Configurable systems and development models.  Use of existing documentation and knowledge.  Effective supplier relationships.  Scalable approach to GXP compliance.  Science based quality risk management system.  Life cycle approach within QMS. 29
  • 30. GAMP5 illustrates the specification, design, and verification process 30
  • 31. APPLICATIONS 1. Monitoring manufacturing, production and storage environments in the pharmaceutical industry. 2. Monitoring the autoclaving process in the pharmaceutical industry. 3. Water purification in the pharmaceutical industry. 4. Freeze drying in the pharmaceutical industry. 31
  • 32. 32

Notas do Editor

  1. si